Skip to main content
. 2013 Apr 17;8(4):e61555. doi: 10.1371/journal.pone.0061555

Table 2. Cisplatin accumulation after four hours of cisplatin exposure and the percentage of cisplatin retention after three hours in drug free medium.

HNSCC cell line IC50 (µM) Cisplatin accumulation (pmol cisplatin/106 cells) Retention (%)
UM-SCC-6 1.12±0.15 922±56 70.4
UM-SCC-11B 2.48±0.16 153±6 79.6
UM-SCC-14A 3.27±0.51 337±12 69.6
UM-SCC-14B 2.35±0.70 242±62 100
UM-SCC-14C 2.60±0.17 91±13 85.9
UM-SCC-22A 0.69±0.32 97±30 100
UM-SCC-22B 0.93±0.31 452±9 74.2
UM-SCC-38 7.57±1.25 373±22 52.6
VU-SCC-040 1.81±0.45 267±10 20.0
VU-SCC-094 0.91±0.13 ND ND
VU-SCC-096 0.99±0.46 588±29 56.5
VU-SCC120 4.03±0.92 176±14 87.9
VU-SCC-147 2.97±0.39 ND ND
VU-SCC-9917 0.99±0.12 258±16 95.5
VU-SCC-OE 1.66±0.25 252±51 98.4
VU-SCC-1131 0.15±0.04 334±114 82.3
VU-SCC-1365 0.80±0.18 275±76 97.3
OHSU-0974 2.99±0.23 275±54 100
FaDu 1.83±0.10 285±90 61.2

Retention (%) represents the remaining cellular cisplatin concentration after three hours in drug free medium. Values are the means of at least duplicate experiments ± SEM. ND; not determined.